← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cybrexa, Inc.
New Haven, CT
$2,300,000
Total funding
1
Grants
Funding over time
peak $1.2M · FY2019–21$2M$1.5M$1M$500K$0
'19
'20
'21
Funding mix
By agency
NIH$2,300,000 · 1
By mechanism
R44$2,300,000 · 1
Investigators at Cybrexa, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of tumor-targeted PARP inhibitors for the treatment of solid cancers$1,179,389
R44 · FY2020 · CA
Development of tumor-targeted PARP inhibitors for the treatment of solid cancers$820,611
R44 · FY2021 · CA
Development of tumor-targeted PARP inhibitors for the treatment of solid cancers$300,000
R44 · FY2019 · CA